What's driving some residents in Palm Springs and the Coachella Valley to seek out health care in Mexico? It turns out it's not just a question of money or cultural familiarity, as Barrett Newkirk reports.
Health Insurance and Costs
Next week, the Center for Health Journalism will host 21 reporters for our 2016 California Fellowship. Fellows and their newsrooms partner with our Center to produce ambitious projects on health topics. Here's a look at the talented crew that will be joining us.
Nearly 4 million Californians lack health insurance coverage, and nearly three out of five uninsured residents are Latino or Hispanic. Is the state and its health exchange, Covered California, doing enough to get Latinos insured?
Obamacare enabled a wave of residents in California’s Central San Joaquin Valley to get health insurance, but finding doctors has been a recurring challenge for many. Is there any relief on the horizon?
On health care, the talk from presidential candidates has been way too sketchy and uninformative, argues contributing editor Trudy Lieberman. Policy details remain vague, and no one has gotten to the heart of what ails the system.
Rural hospitals have been closing at alarming rate across the nation, including California's Central Valley. What happens to rural residents when a local hospital closes it doors? And is telemedicine really the solution?
A new Health Matters webinar this week explored just how different the health care spending map looks when researchers are given access to price and spending data from private insurance plans.
The specialty drug Orkambi, for cystic fibrosis, has a sticker price of $259,000 per year. What's driving these astronomical costs for specialty drugs? And can California's budget cope?
With the third open enrollment period closing last Sunday and predictions suggesting fewer sign-ups than expected, it’s time to be clear about why it’s so difficult to get the remaining holdouts insured.
“Dollars that were intended for a wide array of medical services started being gobbled up by just one drug,” said Charles Bacchi, president of an industry trade group.